DIABETIC MACULAR EDEMA--CLASSIFICATION & NATURAL COURSE
糖尿病性黄斑水肿--分类
基本信息
- 批准号:3426670
- 负责人:
- 金额:$ 5.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-09-30 至 1995-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Investigator's Abstract) "Considerable information is
available concerning the natural course of diabetic retinopathy as it
progresses from the early nonproliferative to the advanced proliferative
stage, and a useful overall scale of retinopathy severity has been
developed. Macular edema, a common feature of diabetic retinopathy and
a common cause of visual loss, is not a part of the retinopathy severity
scale, and its clinical features and natural course have not been well
documented. Existing data from the NEI-sponsored Early Treatment
Diabetic Retinopathy Study (ETDRS) and Diabetic Retinopathy Study (DRS),
in which large numbers of patients with varying degrees of macular edema
and varying retinopathy severity were followed for several years
(initially with one eye randomly assigned to deferral of photo-
coagulation), provide a unique opportunity to document the natural
course of diabetic macular edema and to develop a classification.
Specifically, goals of this project are: (1) to develop a classification
of macular edema based upon fundus photographic and fluorescein
angiographic characteristics; (2) to develop a scale that characterizes
its overall severity; (3) to document its natural course; and (4) to
determine risk factors (demographic, systemic, and ocular) for change
in visual acuity and morphologic characteristics. In addition to
careful examination of relationships using cross-tabulations and
Spearman correlation coefficients, multivariate analyses (including
logistic regression) will be used to establish the predictive value of
selected baseline variables for the outcomes of interest. Since
observations are correlated over time, the mixed effects model described
by Laird and Ware, implemented with the efficient computational methods
of Lindstrom and Bates, will be utilized. Results of these analyses
will be translated into a clinically oriented classification and
severity scale useful both to researchers evaluating treatments and to
ophthalmologists managing patients."
描述(研究者摘要)“大量信息
关于糖尿病视网膜病变的自然病程,
从早期非增殖性进展到晚期增殖性
阶段,和视网膜病变严重程度的有用的整体规模已经
开发黄斑水肿是糖尿病视网膜病变的常见特征,
视力丧失的常见原因,不是视网膜病变严重程度的一部分
规模,其临床特点和自然病程一直没有得到很好的
记录在案。 来自NEI申办的早期治疗的现有数据
糖尿病视网膜病变研究(ETDRS)和糖尿病视网膜病变研究(DRS),
大量患有不同程度黄斑水肿的患者
和不同程度的视网膜病变进行了数年的随访
(最初,一只眼睛随机分配到推迟拍照,
凝血),提供了一个独特的机会,以记录自然的
糖尿病性黄斑水肿的病程及分型。
具体而言,本项目的目标是:(1)制定一个分类
基于眼底照相和荧光素
血管造影特征;(2)制定一个量表,
其整体严重程度;(3)记录其自然过程;(4)
确定变化的风险因素(人口统计学、全身和眼部)
视力和形态特征。 除了
使用交叉表格仔细检查关系,
斯皮尔曼相关系数、多变量分析(包括
逻辑回归)将用于建立的预测值
为感兴趣的结果选择基线变量。 以来
观察值随时间相关,混合效应模型描述了
由Laird和Ware提出,用有效的计算方法实现
将被利用 这些分析结果
将转化为临床导向的分类,
严重程度量表对研究人员评估治疗和
眼科医生管理病人。"
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW D DAVIS其他文献
MATTHEW D DAVIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW D DAVIS', 18)}}的其他基金
Diabetic Macular Edema Clinical Research Network - Fund*
糖尿病性黄斑水肿临床研究网络 - 基金*
- 批准号:
6535521 - 财政年份:2002
- 资助金额:
$ 5.95万 - 项目类别:
DIABETIC MACULAR EDEMA--CLASSIFICATION & NATURAL COURSE
糖尿病性黄斑水肿--分类
- 批准号:
2164056 - 财政年份:1993
- 资助金额:
$ 5.95万 - 项目类别:
RETINAL ARTERY READING CENTER FOR THE ARIC STUDY
ARIC 研究的视网膜动脉读数中心
- 批准号:
2313553 - 财政年份:1992
- 资助金额:
$ 5.95万 - 项目类别:
相似海外基金
The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
- 批准号:
24K19287 - 财政年份:2024
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
以社区为基础的孕前生活方式干预,以预防印度妇女妊娠期糖尿病
- 批准号:
494564 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Operating Grants
Linoleic acid-derived oxylipin species and cognitive function in type 2 diabetes mellitus
亚油酸衍生的氧脂素种类与 2 型糖尿病的认知功能
- 批准号:
495437 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
- 批准号:
23K06224 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathophysiological analysis of the beta cell volume change elicited by pregnancy and gestational diabetes mellitus in Japanese pregnant women
日本孕妇妊娠和妊娠糖尿病引起的β细胞体积变化的病理生理学分析
- 批准号:
23K08020 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis
CXCL10-CXCR3轴在糖尿病牙周炎复合作用中的作用
- 批准号:
10740433 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
The Study of the Association between Gestational Diabetes Mellitus and Mental Health during Pregnancy in Japanese Women
日本女性妊娠期糖尿病与孕期心理健康关系的研究
- 批准号:
23K10101 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized diet therapy useful for glycemic control and quality of life in patients with type 1 diabetes mellitus
个性化饮食疗法有助于 1 型糖尿病患者的血糖控制和生活质量
- 批准号:
23K10809 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidating the Pathophysiology of Gestational Diabetes Mellitus
阐明妊娠糖尿病的病理生理学
- 批准号:
10738361 - 财政年份:2023
- 资助金额:
$ 5.95万 - 项目类别: